All In Biotech

Drug Trial Radar · NCT03247556

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) 400 and 600 mg Efficacy and Safety in Adolescents With ADHD - A Double-Blind, Placebo-Controlled, Pivotal Trial

Last checked: Nov 20, 2026Latest source record: Jul 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Title says "pivotal". Randomized with 297 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

297

Actual

Start

Nov 20, 2017

Primary completion

Feb 14, 2019

Study completion Feb 14, 2019

Sponsor

Lead sponsor
Supernus Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Aug 11, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of high doses of SPN-812 in adolescents (12-17 years old) with ADHD

Conditions

  • ADHD

Interventions

  • PlaceboDrug

    Placebo was administered once daily

  • 400mg SPN-812Drug

    400mg SPN-812 was administered once daily and compared to Placebo

  • 600mg SPN-812Drug

    600mg SPN-812 was administered once daily and compared to Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of SPN-812 Assessed by Attention-Deficit/Hyperactivity Disorder Rating Scale, 5th Edition (ADHD-RS-5)Time frame: Baseline and Week 7 (End of Study)

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Alliance for Wellness dba Alliance for Research

    Long Beach, California

  • MCB Clinical Research Centers, LLC

    Colorado Springs, Colorado

  • Meridien Research at Florida Clinical Research Center

    Bradenton, Florida

  • Innovative Clinical Research, Inc

    Lauderhill, Florida

  • Miami Clinical Research

    Miami, Florida

  • APG Research, LLC

    Orlando, Florida

  • iResearch Atlanta

    Decatur, Georgia

  • IPS Research

    Oklahoma City, Oklahoma

  • Paradigm Research Professionals

    Oklahoma City, Oklahoma

  • Carolina Clinical Trials, Inc.

    Charleston, South Carolina

  • Gadolin Research, LLC

    Beaumont, Texas

  • Bayou City Research Corporation

    Houston, Texas

  • Discovery MM Services Inc. Houston

    Houston, Texas

  • Ericksen Research & Development

    Clinton, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.